InvestorsObserver
×
News Home

Is Ideaya Biosciences Inc (IDYA) a Leader in the Biotechnology Industry?

Wednesday, March 27, 2024 12:00 PM | InvestorsObserver Analysts

Mentioned in this article

Is Ideaya Biosciences Inc (IDYA) a Leader in the Biotechnology Industry?

The 70 rating InvestorsObserver gives to Ideaya Biosciences Inc (IDYA) stock puts it near the top of the Biotechnology industry. In addition to scoring higher than 84 percent of stocks in the Biotechnology industry, IDYA’s 70 overall rating means the stock scores better than 70 percent of all stocks.

Overall Score - 70
IDYA has an Overall Score of 70. Find out what this means to you and get the rest of the rankings on IDYA!

What do These Ratings Mean?

Trying to find the best stocks can be a daunting task. There are a wide variety of ways to analyze stocks in order to determine which ones are performing the strongest. InvestorsObserver makes the entire process easier by using percentile rankings that allows you to easily find the stocks who have the strongest evaluations by analysts.
These scores are not only easy to understand, but it is easy to compare stocks to each other. You can find the best stock in an industry, or look for the sector that has the highest average score. The overall score is a combination of technical and fundamental factors that serves as a good starting point when analyzing a stock. Traders and investors with different goals may have different goals and will want to consider other factors than just the headline number before making any investment decisions.

What's Happening With Ideaya Biosciences Inc Stock Today?

Ideaya Biosciences Inc (IDYA) stock is trading at $43.02 as of 11:58 AM on Wednesday, Mar 27, a gain of $0.51, or 1.2% from the previous closing price of $42.51. The stock has traded between $42.54 and $43.16 so far today. Volume today is below average. So far 92,542 shares have traded compared to average volume of 761,077 shares. Click Here to get the full Stock Report for Ideaya Biosciences Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App